Survival analysis and treatment effects in patients with endometrial cancer and POLE mutations

Cancer. 2021 Nov 15;127(22):4306-4307. doi: 10.1002/cncr.33806. Epub 2021 Jul 27.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • DNA Polymerase II / genetics
  • Endometrial Neoplasms* / genetics
  • Endometrial Neoplasms* / mortality
  • Endometrial Neoplasms* / therapy
  • Female
  • Humans
  • Mutation
  • Survival Analysis

Substances

  • DNA Polymerase II